Global Opioids Drug Market by Manufacturers, Countries, Type and Application, Forecast to 2022

Publisher Name :
Date: 10-Nov-2017
No. of pages: 116

Opioids are a class of drugs that include the illegal drug heroin, synthetic opioids such as fentanyl, and pain relievers available legally by prescription, such as oxycodone (OxyContin?), hydrocodone (Vicodin?), codeine, morphine, and many others. These drugs are chemically related and interact with opioid receptors on nerve cells in the body and brain.

Scope of the Report:

This report focuses on the Opioids Drug in Global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

Market Segment by Manufacturers, this report covers

- Purdue Pharma

- J&J

- Teva

- Mylan

- Depomed

- INSYS

- Endo

- Pfizer

- Hikma

- Mallinckrodt

- Pernix

- Egalet

- Vistapharm

Market Segment by Regions, regional analysis covers

- North America (USA, Canada and Mexico)

- Europe (Germany, France, UK, Russia and Italy)

- Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

- South America (Brazil, Argentina, Columbia etc.)

- Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers

- Oxycodone

- Hydromorphone

- Codeine

- Fentanyl

- Other

Market Segment by Applications, can be divided into

- Pain Relief

- Anesthesia

- Other

There are 15 Chapters to deeply display the global Opioids Drug market.

Chapter 1, to describe Opioids Drug Introduction, product scope, market overview, market opportunities, market risk, market driving force;

Chapter 2, to analyze the top manufacturers of Opioids Drug, with sales, revenue, and price of Opioids Drug, in 2016 and 2017;

Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;

Chapter 4, to show the global market by regions, with sales, revenue and market share of Opioids Drug, for each region, from 2012 to 2017;

Chapter 5, 6, 7, 8 and 9, to analyze the key regions, with sales, revenue and market share by key countries in these regions;

Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2012 to 2017;

Chapter 12, Opioids Drug market forecast, by regions, type and application, with sales and revenue, from 2017 to 2022;

Chapter 13, 14 and 15, to describe Opioids Drug sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source

Global Opioids Drug Market by Manufacturers, Countries, Type and Application, Forecast to 2022

Table of Contents

1 Market Overview
1.1 Opioids Drug Introduction
1.2 Market Analysis by Type
1.2.1 Oxycodone
1.2.2 Hydromorphone
1.2.3 Codeine
1.2.4 Fentanyl
1.2.5 Other
1.3 Market Analysis by Applications
1.3.1 Pain Relief
1.3.2 Anesthesia
1.3.3 Other
1.4 Market Analysis by Regions
1.4.1 North America (USA, Canada and Mexico)
1.4.1.1 USA Market States and Outlook (2012-2022)
1.4.1.2 Canada Market States and Outlook (2012-2022)
1.4.1.3 Mexico Market States and Outlook (2012-2022)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2012-2022)
1.4.2.2 France Market States and Outlook (2012-2022)
1.4.2.3 UK Market States and Outlook (2012-2022)
1.4.2.4 Russia Market States and Outlook (2012-2022)
1.4.2.5 Italy Market States and Outlook (2012-2022)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2012-2022)
1.4.3.2 Japan Market States and Outlook (2012-2022)
1.4.3.3 Korea Market States and Outlook (2012-2022)
1.4.3.4 India Market States and Outlook (2012-2022)
1.4.3.5 Southeast Asia Market States and Outlook (2012-2022)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2012-2022)
1.4.4.2 Egypt Market States and Outlook (2012-2022)
1.4.4.3 Saudi Arabia Market States and Outlook (2012-2022)
1.4.4.4 South Africa Market States and Outlook (2012-2022)
1.4.4.5 Nigeria Market States and Outlook (2012-2022)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Purdue Pharma
2.1.1 Business Overview
2.1.2 Opioids Drug Type and Applications
2.1.2.1 Type 1
2.1.2.2 Type 2
2.1.3 Purdue Pharma Opioids Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2 J&J
2.2.1 Business Overview
2.2.2 Opioids Drug Type and Applications
2.2.2.1 Type 1
2.2.2.2 Type 2
2.2.3 J&J Opioids Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3 Teva
2.3.1 Business Overview
2.3.2 Opioids Drug Type and Applications
2.3.2.1 Type 1
2.3.2.2 Type 2
2.3.3 Teva Opioids Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4 Mylan
2.4.1 Business Overview
2.4.2 Opioids Drug Type and Applications
2.4.2.1 Type 1
2.4.2.2 Type 2
2.4.3 Mylan Opioids Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.5 Depomed
2.5.1 Business Overview
2.5.2 Opioids Drug Type and Applications
2.5.2.1 Type 1
2.5.2.2 Type 2
2.5.3 Depomed Opioids Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.6 INSYS
2.6.1 Business Overview
2.6.2 Opioids Drug Type and Applications
2.6.2.1 Type 1
2.6.2.2 Type 2
2.6.3 INSYS Opioids Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.7 Endo
2.7.1 Business Overview
2.7.2 Opioids Drug Type and Applications
2.7.2.1 Type 1
2.7.2.2 Type 2
2.7.3 Endo Opioids Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.8 Pfizer
2.8.1 Business Overview
2.8.2 Opioids Drug Type and Applications
2.8.2.1 Type 1
2.8.2.2 Type 2
2.8.3 Pfizer Opioids Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.9 Hikma
2.9.1 Business Overview
2.9.2 Opioids Drug Type and Applications
2.9.2.1 Type 1
2.9.2.2 Type 2
2.9.3 Hikma Opioids Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.10 Mallinckrodt
2.10.1 Business Overview
2.10.2 Opioids Drug Type and Applications
2.10.2.1 Type 1
2.10.2.2 Type 2
2.10.3 Mallinckrodt Opioids Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.11 Pernix
2.11.1 Business Overview
2.11.2 Opioids Drug Type and Applications
2.11.2.1 Type 1
2.11.2.2 Type 2
2.11.3 Pernix Opioids Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.12 Egalet
2.12.1 Business Overview
2.12.2 Opioids Drug Type and Applications
2.12.2.1 Type 1
2.12.2.2 Type 2
2.12.3 Egalet Opioids Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.13 Vistapharm
2.13.1 Business Overview
2.13.2 Opioids Drug Type and Applications
2.13.2.1 Type 1
2.13.2.2 Type 2
2.13.3 Vistapharm Opioids Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
3 Global Opioids Drug Market Competition, by Manufacturer
3.1 Global Opioids Drug Sales and Market Share by Manufacturer
3.2 Global Opioids Drug Revenue and Market Share by Manufacturer
3.3 Market Concentration Rate
3.3.1 Top 3 Opioids Drug Manufacturer Market Share
3.3.2 Top 6 Opioids Drug Manufacturer Market Share
3.4 Market Competition Trend
4 Global Opioids Drug Market Analysis by Regions
4.1 Global Opioids Drug Sales, Revenue and Market Share by Regions
4.1.1 Global Opioids Drug Sales by Regions (2012-2017)
4.1.2 Global Opioids Drug Revenue by Regions (2012-2017)
4.2 North America Opioids Drug Sales and Growth (2012-2017)
4.3 Europe Opioids Drug Sales and Growth (2012-2017)
4.4 Asia-Pacific Opioids Drug Sales and Growth (2012-2017)
4.5 South America Opioids Drug Sales and Growth (2012-2017)
4.6 Middle East and Africa Opioids Drug Sales and Growth (2012-2017)
5 North America Opioids Drug by Countries
5.1 North America Opioids Drug Sales, Revenue and Market Share by Countries
5.1.1 North America Opioids Drug Sales by Countries (2012-2017)
5.1.2 North America Opioids Drug Revenue by Countries (2012-2017)
5.2 USA Opioids Drug Sales and Growth (2012-2017)
5.3 Canada Opioids Drug Sales and Growth (2012-2017)
5.4 Mexico Opioids Drug Sales and Growth (2012-2017)
6 Europe Opioids Drug by Countries
6.1 Europe Opioids Drug Sales, Revenue and Market Share by Countries
6.1.1 Europe Opioids Drug Sales by Countries (2012-2017)
6.1.2 Europe Opioids Drug Revenue by Countries (2012-2017)
6.2 Germany Opioids Drug Sales and Growth (2012-2017)
6.3 UK Opioids Drug Sales and Growth (2012-2017)
6.4 France Opioids Drug Sales and Growth (2012-2017)
6.5 Russia Opioids Drug Sales and Growth (2012-2017)
6.6 Italy Opioids Drug Sales and Growth (2012-2017)
7 Asia-Pacific Opioids Drug by Countries
7.1 Asia-Pacific Opioids Drug Sales, Revenue and Market Share by Countries
7.1.1 Asia-Pacific Opioids Drug Sales by Countries (2012-2017)
7.1.2 Asia-Pacific Opioids Drug Revenue by Countries (2012-2017)
7.2 China Opioids Drug Sales and Growth (2012-2017)
7.3 Japan Opioids Drug Sales and Growth (2012-2017)
7.4 Korea Opioids Drug Sales and Growth (2012-2017)
7.5 India Opioids Drug Sales and Growth (2012-2017)
7.6 Southeast Asia Opioids Drug Sales and Growth (2012-2017)
8 South America Opioids Drug by Countries
8.1 South America Opioids Drug Sales, Revenue and Market Share by Countries
8.1.1 South America Opioids Drug Sales by Countries (2012-2017)
8.1.2 South America Opioids Drug Revenue by Countries (2012-2017)
8.2 Brazil Opioids Drug Sales and Growth (2012-2017)
8.3 Argentina Opioids Drug Sales and Growth (2012-2017)
8.4 Columbia Opioids Drug Sales and Growth (2012-2017)
9 Middle East and Africa Opioids Drug by Countries
9.1 Middle East and Africa Opioids Drug Sales, Revenue and Market Share by Countries
9.1.1 Middle East and Africa Opioids Drug Sales by Countries (2012-2017)
9.1.2 Middle East and Africa Opioids Drug Revenue by Countries (2012-2017)
9.2 Saudi Arabia Opioids Drug Sales and Growth (2012-2017)
9.3 UAE Opioids Drug Sales and Growth (2012-2017)
9.4 Egypt Opioids Drug Sales and Growth (2012-2017)
9.5 Nigeria Opioids Drug Sales and Growth (2012-2017)
9.6 South Africa Opioids Drug Sales and Growth (2012-2017)
10 Global Opioids Drug Market Segment by Type
10.1 Global Opioids Drug Sales, Revenue and Market Share by Type (2012-2017)
10.1.1 Global Opioids Drug Sales and Market Share by Type (2012-2017)
10.1.2 Global Opioids Drug Revenue and Market Share by Type (2012-2017)
10.2 Oxycodone Sales Growth and Price
10.2.1 Global Oxycodone Sales Growth (2012-2017)
10.2.2 Global Oxycodone Price (2012-2017)
10.3 Hydromorphone Sales Growth and Price
10.3.1 Global Hydromorphone Sales Growth (2012-2017)
10.3.2 Global Hydromorphone Price (2012-2017)
10.4 Codeine Sales Growth and Price
10.4.1 Global Codeine Sales Growth (2012-2017)
10.4.2 Global Codeine Price (2012-2017)
10.5 Fentanyl Sales Growth and Price
10.5.1 Global Fentanyl Sales Growth (2012-2017)
10.5.2 Global Fentanyl Price (2012-2017)
10.6 Other Sales Growth and Price
10.6.1 Global Other Sales Growth (2012-2017)
10.6.2 Global Other Price (2012-2017)
11 Global Opioids Drug Market Segment by Application
11.1 Global Opioids Drug Sales Market Share by Application (2012-2017)
11.2 Pain Relief Sales Growth (2012-2017)
11.3 Anesthesia Sales Growth (2012-2017)
11.4 Other Sales Growth (2012-2017)
12 Opioids Drug Market Forecast (2017-2022)
12.1 Global Opioids Drug Sales, Revenue and Growth Rate (2017-2022)
12.2 Opioids Drug Market Forecast by Regions (2017-2022)
12.2.1 North America Opioids Drug Market Forecast (2017-2022)
12.2.2 Europe Opioids Drug Market Forecast (2017-2022)
12.2.3 Asia-Pacific Opioids Drug Market Forecast (2017-2022)
12.2.4 South America Opioids Drug Market Forecast (2017-2022)
12.2.5 Middle East and Africa Opioids Drug Market Forecast (2017-2022)
12.3 Opioids Drug Market Forecast by Type (2017-2022)
12.4 Opioids Drug Market Forecast by Application (2017-2022)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Analyst Introduction
15.3 Data Source

List of Tables and Figures

Figure Opioids Drug Picture
Table Product Specifications of Opioids Drug
Figure Global Sales Market Share of Opioids Drug by Types in 2016
Table Opioids Drug Types for Major Manufacturers
Figure Oxycodone Picture
Figure Hydromorphone Picture
Figure Codeine Picture
Figure Fentanyl Picture
Figure Other Picture
Table Opioids Drug Sales Market Share by Applications in 2016
Figure Pain Relief Picture
Figure Anesthesia Picture
Figure Other Picture
Figure USA Opioids Drug Revenue (Value) and Growth Rate (2012-2022)
Figure Canada Opioids Drug Revenue (Value) and Growth Rate (2012-2022)
Figure Mexico Opioids Drug Revenue (Value) and Growth Rate (2012-2022)
Figure Germany Opioids Drug Revenue (Value) and Growth Rate (2012-2022)
Figure France Opioids Drug Revenue (Value) and Growth Rate (2012-2022)
Figure UK Opioids Drug Revenue (Value) and Growth Rate (2012-2022)
Figure Russia Opioids Drug Revenue (Value) and Growth Rate (2012-2022)
Figure Italy Opioids Drug Revenue (Value) and Growth Rate (2012-2022)
Figure China Opioids Drug Revenue (Value) and Growth Rate (2012-2022)
Figure Japan Opioids Drug Revenue (Value) and Growth Rate (2012-2022)
Figure Korea Opioids Drug Revenue (Value) and Growth Rate (2012-2022)
Figure India Opioids Drug Revenue (Value) and Growth Rate (2012-2022)
Figure Southeast Asia Opioids Drug Revenue (Value) and Growth Rate (2012-2022)
Figure Brazil Opioids Drug Revenue (Value) and Growth Rate (2012-2022)
Figure Egypt Opioids Drug Revenue (Value) and Growth Rate (2012-2022)
Figure Saudi Arabia Opioids Drug Revenue (Value) and Growth Rate (2012-2022)
Figure South Africa Opioids Drug Revenue (Value) and Growth Rate (2012-2022)
Figure Nigeria Opioids Drug Revenue (Value) and Growth Rate (2012-2022)
Table Purdue Pharma Basic Information, Manufacturing Base and Competitors
Table Purdue Pharma Opioids Drug Type and Applications
Table Purdue Pharma Opioids Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table J&J Basic Information, Manufacturing Base and Competitors
Table J&J Opioids Drug Type and Applications
Table J&J Opioids Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Teva Basic Information, Manufacturing Base and Competitors
Table Teva Opioids Drug Type and Applications
Table Teva Opioids Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Mylan Basic Information, Manufacturing Base and Competitors
Table Mylan Opioids Drug Type and Applications
Table Mylan Opioids Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Depomed Basic Information, Manufacturing Base and Competitors
Table Depomed Opioids Drug Type and Applications
Table Depomed Opioids Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table INSYS Basic Information, Manufacturing Base and Competitors
Table INSYS Opioids Drug Type and Applications
Table INSYS Opioids Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Endo Basic Information, Manufacturing Base and Competitors
Table Endo Opioids Drug Type and Applications
Table Endo Opioids Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Pfizer Basic Information, Manufacturing Base and Competitors
Table Pfizer Opioids Drug Type and Applications
Table Pfizer Opioids Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Hikma Basic Information, Manufacturing Base and Competitors
Table Hikma Opioids Drug Type and Applications
Table Hikma Opioids Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Mallinckrodt Basic Information, Manufacturing Base and Competitors
Table Mallinckrodt Opioids Drug Type and Applications
Table Mallinckrodt Opioids Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Pernix Basic Information, Manufacturing Base and Competitors
Table Pernix Opioids Drug Type and Applications
Table Pernix Opioids Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Egalet Basic Information, Manufacturing Base and Competitors
Table Egalet Opioids Drug Type and Applications
Table Egalet Opioids Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Vistapharm Basic Information, Manufacturing Base and Competitors
Table Vistapharm Opioids Drug Type and Applications
Table Vistapharm Opioids Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Global Opioids Drug Sales by Manufacturer (2016-2017)
Figure Global Opioids Drug Sales Market Share by Manufacturer in 2016
Figure Global Opioids Drug Sales Market Share by Manufacturer in 2017
Table Global Opioids Drug Revenue by Manufacturer (2016-2017)
Figure Global Opioids Drug Revenue Market Share by Manufacturer in 2016
Figure Global Opioids Drug Revenue Market Share by Manufacturer in 2017
Figure Global Opioids Drug Sales and Growth (2012-2017)
Figure Global Opioids Drug Revenue and Growth (2012-2017)
Table Global Opioids Drug Sales by Regions (2012-2017)
Table Global Opioids Drug Sales Market Share by Regions (2012-2017)
Table Global Opioids Drug Revenue by Regions (2012-2017)
Table Global Opioids Drug Revenue Market Share by Regions in 2012
Table Global Opioids Drug Revenue Market Share by Regions in 2016
Figure North America Opioids Drug Sales and Growth (2012-2017)
Figure Europe Opioids Drug Sales and Growth (2012-2017)
Figure Asia-Pacific Opioids Drug Sales and Growth (2012-2017)
Figure South America Opioids Drug Sales and Growth (2012-2017)
Figure Middle East and Africa Opioids Drug Sales and Growth (2012-2017)
Figure North America Opioids Drug Revenue and Growth (2012-2017)
Table North America Opioids Drug Sales by Countries (2012-2017)
Table North America Opioids Drug Sales Market Share by Countries (2012-2017)
Figure North America Opioids Drug Sales Market Share by Countries in 2012
Figure North America Opioids Drug Sales Market Share by Countries in 2016
Table North America Opioids Drug Revenue by Countries (2012-2017)
Table North America Opioids Drug Revenue Market Share by Countries (2012-2017)
Figure North America Opioids Drug Revenue Market Share by Countries in 2012
Figure North America Opioids Drug Revenue Market Share by Countries in 2016
Figure USA Opioids Drug Sales and Growth (2012-2017)
Figure Canada Opioids Drug Sales and Growth (2012-2017)
Figure Mexico Opioids Drug Sales and Growth (2012-2017)
Figure Europe Opioids Drug Revenue and Growth (2012-2017)
Table Europe Opioids Drug Sales by Countries (2012-2017)
Table Europe Opioids Drug Sales Market Share by Countries (2012-2017)
Table Europe Opioids Drug Revenue by Countries (2012-2017)
Table Europe Opioids Drug Revenue Market Share by Countries in 2012
Table Europe Opioids Drug Revenue Market Share by Countries in 2016
Figure Germany Opioids Drug Sales and Growth (2012-2017)
Figure UK Opioids Drug Sales and Growth (2012-2017)
Figure France Opioids Drug Sales and Growth (2012-2017)
Figure Russia Opioids Drug Sales and Growth (2012-2017)
Figure Italy Opioids Drug Sales and Growth (2012-2017)
Figure Asia-Pacific Opioids Drug Revenue and Growth (2012-2017)
Table Asia-Pacific Opioids Drug Sales by Countries (2012-2017)
Table Asia-Pacific Opioids Drug Sales Market Share by Countries (2012-2017)
Table Asia-Pacific Opioids Drug Sales Market Share by Countries (2012-2017)
Table Asia-Pacific Opioids Drug Revenue by Countries (2012-2017)
Table Asia-Pacific Opioids Drug Revenue Market Share by Countries (2012-2017)
Figure China Opioids Drug Sales and Growth (2012-2017)
Figure Japan Opioids Drug Sales and Growth (2012-2017)
Figure Korea Opioids Drug Sales and Growth (2012-2017)
Figure India Opioids Drug Sales and Growth (2012-2017)
Figure Southeast Asia Opioids Drug Sales and Growth (2012-2017)
Figure South America Opioids Drug Revenue and Growth (2012-2017)
Table South America Opioids Drug Sales by Countries (2012-2017)
Table South America Opioids Drug Sales Market Share by Countries (2012-2017)
Figure South America Opioids Drug Sales Market Share by Countries in 2016
Table South America Opioids Drug Revenue by Countries (2012-2017)
Table South America Opioids Drug Revenue Market Share by Countries (2012-2017)
Figure South America Opioids Drug Revenue Market Share by Countries in 2012
Figure South America Opioids Drug Revenue Market Share by Countries in 2016
Figure Brazil Opioids Drug Sales and Growth (2012-2017)
Figure Argentina Opioids Drug Sales and Growth (2012-2017)
Figure Columbia Opioids Drug Sales and Growth (2012-2017)
Figure Middle East and Africa Opioids Drug Revenue and Growth (2012-2017)
Table Middle East and Africa Opioids Drug Sales by Countries (2012-2017)
Table Middle East and Africa Opioids Drug Sales Market Share by Countries (2012-2017)
Figure Middle East and Africa Opioids Drug Sales Market Share by Countries in 2016
Table Middle East and Africa Opioids Drug Revenue by Countries (2012-2017)
Table Middle East and Africa Opioids Drug Revenue Market Share by Countries (2012-2017)
Figure Middle East and Africa Opioids Drug Revenue Market Share by Countries in 2012
Figure Middle East and Africa Opioids Drug Revenue Market Share by Countries in 2016
Figure Saudi Arabia Opioids Drug Sales and Growth (2012-2017)
Figure UAE Opioids Drug Sales and Growth (2012-2017)
Figure Egypt Opioids Drug Sales and Growth (2012-2017)
Figure Nigeria Opioids Drug Sales and Growth (2012-2017)
Figure South Africa Opioids Drug Sales and Growth (2012-2017)
Table Global Opioids Drug Sales by Type (2012-2017)
Table Global Opioids Drug Sales Share by Type (2012-2017)
Table Global Opioids Drug Revenue by Type (2012-2017)
Table Global Opioids Drug Revenue Share by Type (2012-2017)
Figure Global Oxycodone Sales Growth (2012-2017)
Figure Global Oxycodone Price (2012-2017)
Figure Global Hydromorphone Sales Growth (2012-2017)
Figure Global Hydromorphone Price (2012-2017)
Figure Global Codeine Sales Growth (2012-2017)
Figure Global Codeine Price (2012-2017)
Figure Global Fentanyl Sales Growth (2012-2017)
Figure Global Fentanyl Price (2012-2017)
Figure Global Other Sales Growth (2012-2017)
Figure Global Other Price (2012-2017)
Table Global Opioids Drug Sales by Application (2012-2017)
Table Global Opioids Drug Sales Share by Application (2012-2017)
Figure Global Pain Relief Sales Growth (2012-2017)
Figure Global Anesthesia Sales Growth (2012-2017)
Figure Global Other Sales Growth (2012-2017)
Figure Global Opioids Drug Sales, Revenue and Growth Rate (2017 -2022)
Table Global Opioids Drug Sales Forecast by Regions (2017-2022)
Table Global Opioids Drug Market Share Forecast by Regions (2017-2022)
Figure North America Sales Opioids Drug Market Forecast (2017-2022)
Figure Europe Sales Opioids Drug Market Forecast (2017-2022)
Figure Asia-Pacific Sales Opioids Drug Market Forecast (2017-2022)
Figure South America Sales Opioids Drug Market Forecast (2017-2022)
Figure Middle East and Africa Sales Opioids Drug Market Forecast (2017-2022)
Table Global Opioids Drug Sales Forecast by Type (2017-2022)
Table Global Opioids Drug Market Share Forecast by Type (2017-2022)
Table Global Opioids Drug Sales Forecast by Application (2017-2022)
Table Global Opioids Drug Market Share Forecast by Application (2017-2022)
Table Distributors/Traders/ Dealers List
  • Global Methadone Hydrochloride Sales Market Report 2017
    Published: 13-Nov-2017        Price: US 4000 Onwards        Pages: 101
    In this report, the global Methadone Hydrochloride market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report split global into several key Regions, with sales (K MT), revenue (Million USD), market share and growth rate of Methadone Hydrochloride for these regions, from 2012 to 2022 (forecast), covering - United States - China - Europe ......
  • Global Morphine Sulfate Market Research Report 2017
    Published: 08-Nov-2017        Price: US 2900 Onwards        Pages: 101
    In this report, the global Morphine Sulfate market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report is segmented into several key Regions, with production, consumption, revenue (million USD), market share and growth rate of Morphine Sulfate in these regions, from 2012 to 2022 (forecast), covering - North America - Europe - China - J......
  • Hyperalgesia - Pipeline Insight, 2017
    Published: 01-Nov-2017        Price: US 1250 Onwards        Pages: 50
    DelveInsight's, "Hyperalgesia-Pipeline Insights, 2017", report provides comprehensive insights of the ongoing therapeutic research and development across Hyperalgesia. The report provides a complete understanding of the pipeline activities covering all clinical, pre-clinical and discovery stage products. A comparative pipeline therapeutics assessment of Hyperalgesia by development stage, therapy type, route of administration and molecule type is also covered in the report. It also has a special ......
  • Fibromyalgia -Epidemiology Forecast to 2025
    Published: 01-Nov-2017        Price: US 2750 Onwards        Pages: 40
    DelveInsight "Fibromyalgia - Epidemiology Forecast To 2025" provides an overview of the epidemiology trends of Fibromyalgia in seven major markets (US, France, Germany, Italy, Spain, UK and Japan). It includes 10 years epidemiology historical and forecasted data of Fibromyalgia prevalent or incident cases segmented by age, sex and subpopulations. The Report also discusses the prevailing risk factors, disease burden with special emphasis on the unmet medical need associated with the Fibromyalg......
  • Global Pain Partnering 2010 to 2017
    Published: 01-Nov-2017        Price: US 1495 Onwards        Pages: 200
    "Delivery of this report will take 1-3 days after purchase." The Global Pain Partnering Terms and Agreements since 2010 report provides understanding and access to partnering deals and agreements entered into by the world's leading healthcare companies. • Trends in partnering deals • Top deals by value • Deals listed by company A-Z, industry sector, stage of development, technology type The report provides understanding ......
  • Fibromyalgia - Market Insights, Epidemiology and Market Forecast - 2025
    Published: 01-Nov-2017        Price: US 5750 Onwards        Pages: 70
    DelveInsight's "Fibromyalgia - Market Insights, Epidemiology and Market Forecast - Market Insights, Epidemiology and Market Forecast - 2025" report provides an overview of the disease and in depth research related to Fibromyalgia - Market Insights, Epidemiology and Market Forecast for the 7MM (United States, Germany, France, Italy, Spain and UK) for the study period undertaken from 2015-2025. This report provides understanding of the patients affected, diagnosed patterns, treatm......
  • Global Methadone Hydrochloride Market Research Report 2017
    Published: 31-Oct-2017        Price: US 2900 Onwards        Pages: 105
    In this report, the global Methadone Hydrochloride market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report is segmented into several key Regions, with production, consumption, revenue (million USD), market share and growth rate of Methadone Hydrochloride in these regions, from 2012 to 2022 (forecast), covering - North America - Europe - Ch......
  • Global Methadone Hydrochloride Market Professional Survey Report 2017
    Published: 24-Oct-2017        Price: US 3500 Onwards        Pages: 100
    This report studies Methadone Hydrochloride in Global market, especially in North America, China, Europe, Southeast Asia, Japan and India, with production, revenue, consumption, import and export in these regions, from 2012 to 2016, and forecast to 2022. This report focuses on top manufacturers in global market, with production, price, revenue and market share for each manufacturer, covering - Eli Lilly - Sanofi - Roxane Laboratories - Mallinckrodt......
  • Global Morphine Sulfate Market Professional Survey Report 2017
    Published: 03-Oct-2017        Price: US 3500 Onwards        Pages: 109
    This report studies Morphine Sulfate in Global market, especially in North America, China, Europe, Southeast Asia, Japan and India, with production, revenue, consumption, import and export in these regions, from 2012 to 2016, and forecast to 2022. This report focuses on top manufacturers in global market, with production, price, revenue and market share for each manufacturer, covering - Mallinckrodt Pharmaceuticals - Alcaliber - Purdue Pharma - Cepia-Sa......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs